CLICK HERE TO REGISTER FOR BPN- SMALL MOLECULE WEBINAR
The Blueprint Neurotherapeutics Network for Small Molecule (BPN-Small Molecule), which provides non-dilutive support for small molecule drug discovery and development, from hit-to-lead chemistry through phase I clinical testing, will hold a Q&A Webinar for potential applicants on Tuesday, June 13, 2023.
Program Director Dr. Charles Cywin will provide an overview of the program and answer questions about the application process.
PAR-20-111 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
PAR-20-122 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Next Receipt date for both BPN-Small Molecule Funding Opportunities is August 9th, 2023
All investigators who are interested in learning about the BPN-Small Molecule program are encouraged to register and participate. You can also submit questions before the meeting to Rakonda Medley.
FULL EVENT INFO
Blueprint Neurotherapeutics Network for Small Molecules Q&A Webinar
Tuesday, June 13, 2023 2:00 PM Eastern Time (US and Canada)
Moderated by BPN-Small Molecule Program Director Dr. Charles Cywin
Register in advance for this webinar. After registering, you will receive a confirmation email containing information about joining the webinar.
